30 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
for mRNA Medicines (AMM). With the founding of the Alliance for mRNA Medicines, our community is now poised to champion scientific standards and public
8-K
EX-99.1
rdyzk 0n7ns6m31smh0h
10 Nov 21
Maravai Lifesciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance for 2022
4:09pm
424B4
6us6c 1oqy9k1
13 Sep 21
Prospectus supplement with pricing info
4:16pm
DRS
pj5m5bsm66zdm8c
26 Aug 21
Draft registration statement
12:00am
DEF 14A
t7zd8h55eju7vb5qr6il
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
6f5a6 whlb
9 Apr 21
Preliminary proxy
4:16pm
424B4
mkm42a3ik6eh24az4lx8
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
sxv10gfspu7ki
25 Mar 21
Draft registration statement
12:00am
10-K
4kyj3l qffkj
22 Mar 21
Annual report
4:22pm
8-K
EX-10.1
qm6 f8w23ppfa
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-8
EX-10.2
e51enfy h491m
23 Nov 20
Registration of securities for employees
5:06pm
424B4
u6g7lvlmfebjewm0ye
23 Nov 20
Prospectus supplement with pricing info
4:36pm